Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Garzotto

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Techniques in Vascular and Interventional Radiology|December 19, 2012
Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapyRyan Priest, Mark Garzotto, John Kaufman
Urology|January 26, 2005
Radical retropubic prostatectomy after orthotopic liver transplantationAaron Bayne, John M Barry, Mark Garzotto
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 12, 2010
Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localizationArthur Y Hung, Mark Garzotto, Darryl Kaurin
American Journal of Clinical Oncology|December 15, 2004
High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancerTomasz M Beer, Mark Garzotto, Nina M Katovic
Communications Medicine|May 6, 2025
Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in menKate R Bowie, Mark Garzotto, Eric Orwoll, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in menKate R Bowie, Mark Garzotto, Eric Orwoll, et al.
The Journal of Urology|April 11, 2003
Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapyTomasz M Beer, Mark Garzotto, Kristi M Eilers, et al.
Urologic Oncology|May 9, 2006
Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancerMark Garzotto, Anne Myrthue, Celestia S Higano, et al.
Urology|July 1, 2006
Metastatic adenocarcinoma of prostate in a healing sternotomy siteGreg Adams, Amanda Mitchell, Ravi Ravichandran, et al.
Clinical Genitourinary Cancer|January 24, 2007
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?Jennifer L Lycette, Lisa B Bland, Mark Garzotto, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Techniques in Vascular and Interventional Radiology|December 19, 2012
Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapyRyan Priest, Mark Garzotto, John Kaufman
Urology|January 26, 2005
Radical retropubic prostatectomy after orthotopic liver transplantationAaron Bayne, John M Barry, Mark Garzotto
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 12, 2010
Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localizationArthur Y Hung, Mark Garzotto, Darryl Kaurin
American Journal of Clinical Oncology|December 15, 2004
High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancerTomasz M Beer, Mark Garzotto, Nina M Katovic
Communications Medicine|May 6, 2025
Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in menKate R Bowie, Mark Garzotto, Eric Orwoll, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in menKate R Bowie, Mark Garzotto, Eric Orwoll, et al.
The Journal of Urology|April 11, 2003
Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapyTomasz M Beer, Mark Garzotto, Kristi M Eilers, et al.
Urologic Oncology|May 9, 2006
Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancerMark Garzotto, Anne Myrthue, Celestia S Higano, et al.
Urology|July 1, 2006
Metastatic adenocarcinoma of prostate in a healing sternotomy siteGreg Adams, Amanda Mitchell, Ravi Ravichandran, et al.
Clinical Genitourinary Cancer|January 24, 2007
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?Jennifer L Lycette, Lisa B Bland, Mark Garzotto, et al.
Pageof 8